Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biased ligands at G-protein-coupled receptors: promise and progress
Jonathan D. Violin, Aimee L. Crombie, David G. Soergel, et al.
Trends in Pharmacological Sciences (2014) Vol. 35, Iss. 7, pp. 308-316
Closed Access | Times Cited: 336

Showing 1-25 of 336 citing articles:

Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser, Misty M. Attwood, Mathias Rask‐Andersen, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 12, pp. 829-842
Open Access | Times Cited: 2253
Molecular Dynamics Simulation for All
Scott A. Hollingsworth, Ron O. Dror
Neuron (2018) Vol. 99, Iss. 6, pp. 1129-1143
Open Access | Times Cited: 1911
Poorly controlled postoperative pain: prevalence, consequences, and prevention
Tong J. Gan
Journal of Pain Research (2017) Vol. Volume 10, pp. 2287-2298
Open Access | Times Cited: 1093
The Current State of Peptide Drug Discovery: Back to the Future?
Antoine Henninot, James C. Collins, John M. Nuss
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 4, pp. 1382-1414
Closed Access | Times Cited: 931
GPCR Dynamics: Structures in Motion
Naomi R. Latorraca, AJ Venkatakrishnan, Ron O. Dror
Chemical Reviews (2016) Vol. 117, Iss. 1, pp. 139-155
Open Access | Times Cited: 672
Biased signalling: from simple switches to allosteric microprocessors
Jeffrey S. Smith, Robert J. Lefkowitz, Sudarshan Rajagopal
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 4, pp. 243-260
Open Access | Times Cited: 642
Illuminating G-Protein-Coupling Selectivity of GPCRs
Asuka Inoue, Francesco Raimondi, Francois Marie Ngako Kadji, et al.
Cell (2019) Vol. 177, Iss. 7, pp. 1933-1947.e25
Open Access | Times Cited: 529
Breaking barriers to novel analgesic drug development
Ajay Yekkirala, David P. Roberson, Bruce P. Bean, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 8, pp. 545-564
Open Access | Times Cited: 313
The role of kinetic context in apparent biased agonism at GPCRs
Carmen Klein Herenbrink, David A. Sykes, Prashant Donthamsetti, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 312
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists
Alexander Gillis, Arisbel B. Gondin, Andrea Kliewer, et al.
Science Signaling (2020) Vol. 13, Iss. 625
Open Access | Times Cited: 310
Structure and function of serotonin G protein-coupled receptors
John D. McCorvy, Bryan L. Roth
Pharmacology & Therapeutics (2015) Vol. 150, pp. 129-142
Open Access | Times Cited: 308
Multidimensional Tracking of GPCR Signaling via Peroxidase-Catalyzed Proximity Labeling
Jaeho Paek, Marian Kalocsay, Dean P. Staus, et al.
Cell (2017) Vol. 169, Iss. 2, pp. 338-349.e11
Open Access | Times Cited: 251
Biased agonism: An emerging paradigm in GPCR drug discovery
Zoran Ranković, Tarsis F. Brust, Laura Bohn
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 26, Iss. 2, pp. 241-250
Open Access | Times Cited: 246
Biased Receptor Signaling in Drug Discovery
Terry Kenakin
Pharmacological Reviews (2019) Vol. 71, Iss. 2, pp. 267-315
Open Access | Times Cited: 246
CB2Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?
Amey Dhopeshwarkar, Ken Mackie
Molecular Pharmacology (2014) Vol. 86, Iss. 4, pp. 430-437
Open Access | Times Cited: 245
PTH receptor-1 signalling—mechanistic insights and therapeutic prospects
Ross W. Cheloha, Samuel H. Gellman, Jean‐Pierre Vilardaga, et al.
Nature Reviews Endocrinology (2015) Vol. 11, Iss. 12, pp. 712-724
Open Access | Times Cited: 230
GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures
Ichio Shimada, Takumi Ueda, Yutaka Kofuku, et al.
Nature Reviews Drug Discovery (2018) Vol. 18, Iss. 1, pp. 59-82
Open Access | Times Cited: 217
Advances in G Protein-Coupled Receptor Allostery: From Function to Structure
Arthur Christopoulos
Molecular Pharmacology (2014) Vol. 86, Iss. 5, pp. 463-478
Open Access | Times Cited: 211
A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain
Eugene R. Viscusi, Lynn R. Webster, Michael E. Kuss, et al.
Pain (2015) Vol. 157, Iss. 1, pp. 264-272
Closed Access | Times Cited: 185
Molecular mechanism of GPCR-mediated arrestin activation
Naomi R. Latorraca, Jason K. Wang, Brian Bauer, et al.
Nature (2018) Vol. 557, Iss. 7705, pp. 452-456
Open Access | Times Cited: 185
Structural Basis for G Protein-Coupled Receptor Activation
Aashish Manglik, Andrew C. Kruse
Biochemistry (2017) Vol. 56, Iss. 42, pp. 5628-5634
Open Access | Times Cited: 174
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 156
Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD
Can Cao, Ximena Barros-Álvarez, Shicheng Zhang, et al.
Neuron (2022) Vol. 110, Iss. 19, pp. 3154-3167.e7
Open Access | Times Cited: 102
Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential
Jason Wallach, Andrew B. Cao, Maggie M. Calkins, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
New paradigms in GPCR drug discovery
Kenneth A. Jacobson
Biochemical Pharmacology (2015) Vol. 98, Iss. 4, pp. 541-555
Open Access | Times Cited: 163
Page 1 - Next Page

Scroll to top